Cro Europe Companies - Top Cros In Europe
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

pharmtrace: Delivering Improved Outcomes in Clinical Trials
line

Top 10 CROs in Europe - 2021

line

Today, pharma companies are under greater economic and regulatory pressure than ever. On the one hand, we are seeing costs of drug development shooting up in the past decade. And on the other hand, we see a lot of new regulatory guidelines in terms of medicine efficacy being implemented at length. These challenges are expected to intensify even further in the coming months as the demand for improved safety data and comparative efficacy studies grows.

Amid this landscape, many pharma companies are looking for innovations and smarter ways of doing business. One of the major trends resulting from high costs is companies outsourcing their clinical research activities to contract research organisations (CROs). These service providers can support pharma companies with a wide range of services like preclinical evaluations, study design, clinical trial planning and management, independent safety data monitoring, bio-statistical analysts and many more.

Amid such trends making a wave in the pharma sector, organisations must equip themselves with the latest and most effective technologies. In order to assist such companies in shoring up their capabilities, we have compiled this issue of Pharma Tech Outlook Europe. In this edition, we have listed the top 10 CROs in Europe to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted service providers are transforming the pharma landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts and CXOs on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook Europe helps you build the partnership you and your organisation need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook Europe’s “Top 10 CROs in Europe – 2021.”

    Top CROs in Europe

  • BlueClinical is a privately owned independent full-service CRO focused on bioequivalence and early-stage clinical studies in healthy subjects and patients, translational medicine consultancy, and site management. We provide highly-customized and fully-compliant services, to maximize client’s competitiveness and time-to-market. This includes liaison with regulatory authorities (including US FDA and EMA), when needed to ensure the protocol meets the required criteria. BlueClinical’s own Clinical Pharmacology Unit (CPU) is in Porto, Portugal. Our 61-bed clinical ward benefits from its hospital location for access to logistic services and emergency support.

    www.blueclinical.com

  • Cardialysis is a leading specialized Clinical Research Organization (CRO) with an exclusive focus on cardiology, providing a full range of clinical research and cardiovascular Core Laboratory services. Founded in 1983, Cardialysis is recognized for its opinion-leader expertise, strong academic network and in-depth cardiology expertise and in recent years has significantly expanded its operational activities. The world’s top medical device, biotechnology and pharmaceutical companies have been collaborating with Cardialysis in more than 400 clinical trials conducted thus far, contributing to improved cardiovascular therapies.

    www.cardialysis.com

  • Coronis delivers a full spectrum of services to national and international pharmaceutical, biotechnology and medical device companies and other healthcare-related organisations

    coronis.gr

  • pharmtrace was founded to help leverage the potential of imaging and nuclear medicine in drug and medical device clinical trials.As an independent CRO, pharmtraceoffers flexible and robust CRO services for studies with imaging endpoints, radiopharmaceuticals, and radiological interventional procedures.The company’s proprietary image management platform—ERICA—is an image database and reading system that orchestrates efficient processes and complete transparency for sponsors. The cloud-based GCP-compliant platform enables site personnel to securely upload images to the ERICA warehouse, which are pseudonymized during upload. Moreover, pharmtracealso looks at each study from the regulatory perspective and on the defensibility of the imaging read-out in regulatory discussions. This approach helps sponsors to gain a realistic understanding of the potential value and importantly the limitations of imaging in the specific trial context

    pharmtrace.com

  • Porsolt is a long-established preclinical CRO, having started operations in 1984 under the name ITEM-Labo. Porsolt has obtained an international reputation for expertise in physiopathological models, customized procedures and tailored solutions for discovering treatments of psychiatric and neurological disorders, acute and chronic pain, inflammation, cardiac and vascular diseases, and metabolic and eating disorders. Porsolt also offers services for safety evaluation of drug candidates from screening to pre-Phase 1 regulatory studies (ICH S7), in full compliance with GLP. Porsolt’s safety program includes full assessment of arrhythmogenic risk and abuse/dependence liability. Porsolt is headquartered in France with research facilities in Laval.

    www.porsolt.com

  • Accelsiors

    Accelsiors

    Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development. Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives.

  • CONET GmbH

    CONET GmbH

    CONET GmbH is a privately owned and managed full service CRO offering a complete range of clinical trial services. As a medium-sized and owner-managed company, we offer the advantages of a flat hierarchy, short decision paths and a strong sense of personal responsibility in daily business. The size and structure of our organization allows us to operate with the high flexibility and cost-effectiveness of a small CRO, while at the same time offering the expertise of our international presence. We have developed long-term customer relationships with clients located in all ICH countries (European Union (EU), US and Japan) based on our consistent high quality performance and reliability.

  • DICE

    DICE

    DICE is a Contract Research Organization with over 30 years of experience in the execution of clinical trials. We have assisted in the execution of Phase I-IV studies and supported in the defense at EMA and FDA with clients from across the globe. We have expertise in an array of therapeutic areas and experience in the development of different medical technologies. DICE offers a variety of services including: Clinical Study Design, Clinical Data Management, Biostatistical Analysis, Medical Writing, Central Imaging Review, and Medical Monitoring. Our mission is to enhance access to medical treatment by delivering excellence in the design and execution of clinical trials. Our knowledgeable and dedicated team of experts have a drive and curiosity that encourages them to take on projects as if they were their own. At DICE, your success is our own success.

  • HungaroTrial

    HungaroTrial

    HungaroTrial is a market-leading regional CRO in Central and Eastern Europe specializing in hosting phase I – IV clinical trials with quick start up times, patient enrolment guarantee and premium quality. With 20 years of successful operations in CEE region, 12 in-house MDs, and expert advisors we are ideally placed to host your clinical studies. Beside clinical trials, we also offer regulatory support. Accessing the EU market was always challenging, and now with the new MDR in force it will be even more so. We can assist you navigate the new challenges MDR presents, and ensure you will gain market access.

  • Brillance Sp. z o.o.

    Brillance Sp. z o.o.

    Brillance Sp. z o.o. is an entirely independent and private Polish CRO (Contract Research Organization) – a company providing clinical trials management and monitoring services for pharmaceutical industry. Our activities are focused on research and development services for medical, pharmaceutical and biotechnology industries. Comprehensive range of professional services offered by Brillance includes: monitoring and management of phase I – IV clinical trials and concerns both local and big international complex projects in many therapeutic areas. We provide preparation and extensive training for Polish sites (hospitals, outpatient units) in order to encourage and train them to conduct local and international clinical trial projects. For our clients, we have a wide range offer of additional services, such as: study feasibility (site and investigators selection), staff outsourcing for CROs and medical/pharmaceutical companies, and data management services. We are proud to implement GCP principles in medical and pharmaceutical environment. Our clients are famous Polish and international leading medical, pharmaceutical and biotechnology companies.